Teaser text

Specialising in microbiome data analytics for biomarker discovery focused on chronic inflammatory diseases of the digestive tract, and gastrointestinal cancers in particular.

Body Text

Competitive advantage

  • Expertise in deep profiling of the human microbiome documented in high impact outputs
  • Documented capacity to perform multi-omics strategies
  • Long-term experience with the handling and extraction of a range of clinical samples


  • Profiling the human microbiome – now causally linked to a range of diseases that fall within the broad themes of cancer, infectious disease, non-communicable diseases and mental health – using next generation sequencing and big data analytics.

Successful outcomes

  • Identified microbial signatures associated with therapeutic efficacy of faecal microbiota transplantation in ulcerative colitis
  • Identified novel associations between the oesophageal microbiome and the progression of the oesophageal adenocarcinoma cascade

Capabilities and facilities

  • Experience in study design, patient recruitment and sample collection for optimal downstream analysis
  • Handling and extraction of clinical samples of diverse origins
  • Access to next-generation sequencing facilities and computing infrastructure to handle big data
  • Established data analysis pipelines for signature discovery

Our partners

  • Extensive list of clinical